![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/431 | |
A61K 31/546 | |||
A61K 9/19 | |||
A61P 31/00 | |||
A61P 43/00 |
(11) | Number of the document | 3043797 |
(13) | Kind of document | T |
(96) | European patent application number | 14842042.5 |
Date of filing the European patent application | 2014-09-09 | |
(97) | Date of publication of the European application | 2016-07-20 |
(45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/054757 |
Date | 2014-09-09 |
(87) | Number | WO 2015/035376 |
Date | 2015-03-12 |
(30) | Number | Date | Country code |
201361875358 P | 2013-09-09 | US | |
201361883579 P | 2013-09-27 | US | |
201461984299 P | 2014-04-25 | US | |
201461988085 P | 2014-05-02 | US | |
201462002457 P | 2014-05-23 | US | |
201462046417 P | 2014-09-05 | US |
(72) |
KRISHNA, Gopal, US
HERSHBERGER, Elham, US
CHANDORKAR, Gurudatt, US
MILLER, Benjamin, US
XIAO, Alan, US
|
(73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
(54) | TREATING INFECTIONS WITH CEFTOLOZANE/TAZOBACTAM IN SUBJECTS HAVING IMPAIRED RENAL FUNCTION |
TREATING INFECTIONS WITH CEFTOLOZANE/TAZOBACTAM IN SUBJECTS HAVING IMPAIRED RENAL FUNCTION |